跳至主要内容
临床试验/NCT01305733
NCT01305733Unknown不适用

Local Infiltration Analgesia During Total Knee Arthroplasty - Reduced Opiate Consumption and Faster Mobilisation Postoperatively - Randomized Controlled Trial

Coxa, Hospital for Joint Replacement2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
2
主要终点
oxycodone consumption during the first 48 postoperative hours

研究概览

简要总结

The primary objective is to evaluate whether local infiltration analgesia (LIA) will reduce oxycodone consumption during the first 48 postoperative hours in patients undergoing total knee arthroplasty (TKA).

详细描述

The goal of LIA is to gain an effective and safe pain control during the first postoperative days. The study is a single-center, randomized controlled trial, which will be performed in Coxa Hospital for Joint Replacement in Tampere, Finland. The injectant mixture consists of 150 mg levobupivacaine mixed with 30 mg ketorolac and 0.5 mg adrenaline with occasional variations if the patient is unusually small, very elderly, infirm or has a history of significant intolerance to analgesics or anesthetic agents. The RKA mixture is diluted with normal saline. Total volume of the solution is 100 ml depending on the size of the wound. The normal saline injection are used in the control group in the same manner than in the RKA group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients requiring primary TKA for primary OA
  • Patients aged 75 years or less
  • Patients suitable for all applicable devices

排除标准

  • Rheumatoid arthritis or other inflammatory diseases
  • Patients requiring bone grafting during surgery
  • Unwilling to provide informed consent
  • BMI > 35
  • Renal dysfunction
  • Allergic to ASA
  • Previous high tibial osteotomy or previous osteosynthesis
  • > 15 degrees varus / valgus malalignment
  • Physical, emotional or neurological conditions which would comprise the patient´s compliance with postoperative rehabilitation and follow-up (e.g. drug or alcohol abuse, serious mental illness, general neurological conditions such as Parkinson, MS, etc.)
  • Known sensitivity to materials in the devices

研究组 & 干预措施

local infiltration analgesia

Active Comparator

The injectant mixture consists of 150 mg levobupivacaine mixed with 30 mg ketorolac and 0.5 mg adrenaline

干预措施: The injectant mixture consists of 150 mg levobupivacaine mixed with 30 mg ketorolac and 0.5 mg adrenaline (Drug)

saline injection

Placebo Comparator

The normal saline injection are used in the control group in the same manner than in the RKA group.

干预措施: saline injection (Other)

结局指标

主要结局

oxycodone consumption during the first 48 postoperative hours

时间窗: 48 hours

次要结局

  • functional outcome after TKA(1 year)

研究者

发起方
Coxa, Hospital for Joint Replacement
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mika Niemeläinen

orthopaedic surgeon

Coxa, Hospital for Joint Replacement

研究点 (2)

Loading locations...

相似试验